Scaffolds of bioactive glass-ceramic (Biosilicate®) and bone healing: A biological evaluation in an experimental model of tibial bone defect in rats

Biomed Mater Eng. 2018;29(5):665-683. doi: 10.3233/BME-181016.

Abstract

This study aimed to investigate the in vivo tissue response of the Biosilicate® scaffolds in a model of tibial bone defect. Sixty male Wistar rats were distributed into bone defect control group (CG) and Biosilicate® scaffold group (BG). Animals were euthanized 15, 30 and 45 days post-surgery. Stereomicroscopy, scanning electron microscopy, histopathological, immunohistochemistry and biomechanical analysis were used. Scaffolds had a total porosity of 44%, macroporosity of 15% with pore diameter of 230 μm. Higher amount of newly formed bone was observed on days 30 and 45 in BG. Immunohistochemistry analysis showed that the COX-2 expression was significantly higher on days 15 and 30 in BG compared with the CG. RUNX-2 immunoexpression was significantly higher in BG on days 15 and 45. No statistically significant difference was observed in RANKL immunoexpression in all experimental groups. BMP-9 immunoexpression was significantly upregulated in the BG on day 45. Biomechanical analysis showed a decrease in the biomechanical properties of the bone callus on days 30 and 45. The implantation of the Biosilicate® scaffolds was effective in stimulating newly bone formation and produced an increased immunoexpression of markers related to the bone repair.

Keywords: Biosilicate®; bone repair; glass-ceramic; rats; scaffold.

MeSH terms

  • Animals
  • Biomechanical Phenomena
  • Bone Substitutes / chemistry*
  • Fracture Healing
  • Glass / chemistry*
  • Male
  • Osteogenesis
  • Rats
  • Rats, Wistar
  • Tibia / injuries
  • Tibia / pathology*
  • Tibial Fractures / pathology
  • Tibial Fractures / therapy*
  • Tissue Scaffolds / chemistry*

Substances

  • Bone Substitutes
  • sodium oxide-calcium oxide-silicon dioxide-diphosphorus pentoxide